Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06161974
Title Study of Olutasidenib and Temozolomide in HGG
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Nationwide Children's Hospital
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | NLD | GBR | DEU | CAN | AUS

Additional content available in CKB BOOST